In agreement, both TREX1 and RNASEH2B deficiencies have been clinically associated with inflammatory symptoms such as inflammatory myopathy (Tumiene et al., 2017) and systemic inflammation (He et al., 2021). This evidence concerns the gene TREX1 and myopathy.